Annual CFF
$101.32 M
-$200.47 M-66.43%
December 31, 2023
Summary
- As of February 8, 2025, ARQT annual cash flow from financing activities is $101.32 million, with the most recent change of -$200.47 million (-66.43%) on December 31, 2023.
- During the last 3 years, ARQT annual CFF has fallen by -$196.82 million (-66.02%).
- ARQT annual CFF is now -66.43% below its all-time high of $301.80 million, reached on December 31, 2022.
Performance
ARQT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$394.00 K
-$1.06 M-72.92%
September 30, 2024
Summary
- As of February 8, 2025, ARQT quarterly cash flow from financing activities is $394.00 thousand, with the most recent change of -$1.06 million (-72.92%) on September 30, 2024.
- Over the past year, ARQT quarterly CFF has dropped by -$473.00 thousand (-54.56%).
- ARQT quarterly CFF is now -99.86% below its all-time high of $284.99 million, reached on September 30, 2022.
Performance
ARQT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$262.90 M
-$473.00 K-0.18%
September 30, 2024
Summary
- As of February 8, 2025, ARQT TTM cash flow from financing activities is $262.90 million, with the most recent change of -$473.00 thousand (-0.18%) on September 30, 2024.
- Over the past year, ARQT TTM CFF has increased by +$259.91 million (+8675.10%).
- ARQT TTM CFF is now -29.65% below its all-time high of $373.72 million, reached on September 30, 2022.
Performance
ARQT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ARQT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -66.4% | -54.6% | +8675.1% |
| 3 y3 years | -66.0% | -54.6% | +8675.1% |
| 5 y5 years | +64.5% | -54.6% | +8675.1% |
ARQT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -66.4% | at low | -99.9% | +294.0% | -29.6% | +8675.1% |
| 5 y | 5-year | -66.4% | +8.8% | -99.9% | +190.2% | -29.6% | +8675.1% |
| alltime | all time | -66.4% | +1323.3% | -99.9% | +190.2% | -29.6% | -100.0% |
Arcutis Biotherapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $394.00 K(-72.9%) | $262.90 M(-0.2%) |
| Jun 2024 | - | $1.46 M(-99.1%) | $263.38 M(+0.1%) |
| Mar 2024 | - | $161.76 M(+62.9%) | $262.99 M(+159.6%) |
| Dec 2023 | $101.32 M(-66.4%) | $99.29 M(>+9900.0%) | $101.32 M(+3281.9%) |
| Sep 2023 | - | $867.00 K(-18.7%) | $3.00 M(-99.0%) |
| Jun 2023 | - | $1.07 M(+967.0%) | $287.12 M(-0.0%) |
| Mar 2023 | - | $100.00 K(-89.6%) | $287.18 M(-4.8%) |
| Dec 2022 | $301.80 M(+7.0%) | $962.00 K(-99.7%) | $301.80 M(-19.2%) |
| Sep 2022 | - | $284.99 M(>+9900.0%) | $373.72 M(+320.9%) |
| Jun 2022 | - | $1.13 M(-92.3%) | $88.79 M(-0.1%) |
| Mar 2022 | - | $14.72 M(-79.8%) | $88.85 M(-68.5%) |
| Dec 2021 | $281.95 M | $72.88 M(>+9900.0%) | $281.95 M(-16.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $63.00 K(-94.7%) | $338.45 M(+0.1%) |
| Jun 2021 | - | $1.19 M(-99.4%) | $337.95 M(+0.3%) |
| Mar 2021 | - | $207.81 M(+60.6%) | $337.07 M(+13.1%) |
| Dec 2020 | $298.14 M(+220.2%) | $129.38 M(<-9900.0%) | $298.14 M(+13.9%) |
| Sep 2020 | - | -$437.00 K(-241.4%) | $261.72 M(-0.2%) |
| Jun 2020 | - | $309.00 K(-99.8%) | $262.14 M(+0.1%) |
| Mar 2020 | - | $168.89 M(+81.7%) | $262.00 M(+181.4%) |
| Dec 2019 | $93.10 M(+51.2%) | $92.95 M(<-9900.0%) | $93.10 M(>+9900.0%) |
| Sep 2019 | - | -$20.00 K(-111.9%) | $148.00 K(-11.9%) |
| Jun 2019 | - | $168.00 K(>+9900.0%) | $168.00 K(>+9900.0%) |
| Mar 2019 | - | $0.00 | $0.00 |
| Dec 2018 | $61.59 M(+765.2%) | - | - |
| Dec 2017 | $7.12 M | - | - |
FAQ
- What is Arcutis Biotherapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual CFF year-on-year change?
- What is Arcutis Biotherapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly CFF year-on-year change?
- What is Arcutis Biotherapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics TTM CFF year-on-year change?
What is Arcutis Biotherapeutics annual cash flow from financing activities?
The current annual CFF of ARQT is $101.32 M
What is the all time high annual CFF for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual cash flow from financing activities is $301.80 M
What is Arcutis Biotherapeutics annual CFF year-on-year change?
Over the past year, ARQT annual cash flow from financing activities has changed by -$200.47 M (-66.43%)
What is Arcutis Biotherapeutics quarterly cash flow from financing activities?
The current quarterly CFF of ARQT is $394.00 K
What is the all time high quarterly CFF for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly cash flow from financing activities is $284.99 M
What is Arcutis Biotherapeutics quarterly CFF year-on-year change?
Over the past year, ARQT quarterly cash flow from financing activities has changed by -$473.00 K (-54.56%)
What is Arcutis Biotherapeutics TTM cash flow from financing activities?
The current TTM CFF of ARQT is $262.90 M
What is the all time high TTM CFF for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high TTM cash flow from financing activities is $373.72 M
What is Arcutis Biotherapeutics TTM CFF year-on-year change?
Over the past year, ARQT TTM cash flow from financing activities has changed by +$259.91 M (+8675.10%)